Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

277

HTML

2034

Figures (1-1)

170

Tables (1-4)

165

Sum=2646

May 21, 2005 (publication date) through Jul 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. May 21, 2005; 11(19): 2975-2980
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2975

Table 3 Correlation of pathological factors and expression of syndecan-1.

	Syndecan-1 expression		P
	*Positive (n =* 80)**	*Negative (n =* 40)**	P
Histology
Solely differentiated type	66	16	<0.05
Complex type	14	24	<0.05
Lymphatic and/or venous invasion¹	28	13	NS
Lymph node metastasis	12	8	NS
IM with G-type²	2	6	<0.05

G-type, gastric type; NS, not significant.

¹Evaluated in 41 surgically resected specimens with submucosal invasion.

²Evaluated in 85 cases with positive for IM.

Citation: Huang MF, Zhu YQ, Chen ZF, Xiao J, Huang X, Xiong YY, Yang GF. Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. World J Gastroenterol 2005; 11(19): 2975-2980
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2975.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2975